PHASE I TRIAL OF INTRATUMORAL AND RESECTION CAVITY ADMINISTRATION OF A MEASLES VIRUS DERIVATIVE EXPRESSING THE HUMAN CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Galanis, Evanthia [1 ]
O'Neill, Brian [1 ]
Piepgras, David [1 ]
Meyer, Fredric [1 ]
Uhm, Joon [1 ]
Marks, Randolph [1 ]
Hammack, Julie [1 ]
Lachance, Daniel [1 ]
Anderson, S. Keith [1 ]
Wu, Wenting [1 ]
Russell, Stephen [1 ]
Buckner, Jan [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：819 / 819
页数：1
相关论文
共 50 条
  • [41] Preclinical Toxicology Assessment of Intracranial Administration of an Oncolytic Measles Virus Strain Armed with H. pylori Neutrophil-Activating Protein Prior to Phase I Trial in Glioblastoma Patients
    Viker, Kim
    Concilio, Susanna C.
    Clark, Susan M.
    Robinson, Steven
    Dyer, Roy
    Gades, Naomi
    Pattengill, Jenny
    Iankov, Ianko D.
    Galanis, Evanthia
    MOLECULAR THERAPY, 2024, 32 (04) : 825 - 825
  • [42] A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF INCREASING DOSES OF IPILIMUMAB PLUS FIXED DOSE NIVOLUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGB)
    Geens, Wietse
    Schwarze, Julia Katharina
    Tijtgat, Jens
    Lescrauwaet, Louise
    Tuyaerts, Sandra
    Geeraerts, Xenia
    Stevens, Latoya
    Vanbinst, Anne-Marie
    Everaert, Hendrik
    Bruneau, Michael
    Duerinck, Johnny
    Neyns, Bart
    NEURO-ONCOLOGY, 2022, 24 : 62 - 62
  • [43] Repeated intracranial administration of ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial
    Geens, W.
    Schwarze, J. K.
    Awada, G.
    Tijtgat, J.
    Lescrauwet, L.
    Geeraerts, X.
    Vaeyens, F.
    Cras, L.
    Van Binst, A.
    Everaert, H.
    Michotte, A.
    Cauwenbergh, T.
    Bruneau, M.
    Forsyth, R.
    Tuyaerts, S.
    Neyns, B.
    Duerinck, J.
    NEURO-ONCOLOGY, 2022, 24
  • [44] Toxicology and Pharmacology Studies on an Indiana Strain Vesicular Stomatitis Virus Expressing the Human Interferon Beta Protein for a Phase I Trial in Patients With Recurrent Hepatocellular Carcinoma
    Myers, R.
    Greiner, S.
    Thompson, J.
    Jenks, N.
    Greenslade, A.
    Mader, E.
    Federspiel, M.
    Russell, S. J.
    Barber, G.
    Rakela, J.
    Borad, M.
    Vile, R.
    Peng, K. W.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2009, 28 (01) : 60 - 60
  • [45] Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
    Patel, Daxa M.
    Foreman, Paul M.
    Nabors, L. Burt
    Riley, Kristen O.
    Gillespie, G. Yancey
    Markert, James M.
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2016, 27 (02) : 69 - 78
  • [46] Treatment of Progressive or Recurrent Glioblastoma Multiforme in Adults with Herpes Simplex Virus Thymidine Kinase Gene Vector-Producer Cells Followed by Intravenous Ganciclovir Administration: A Phase I/II Multi-Institutional Trial
    Michael D. Prados
    Michael McDermott
    Susan M. Chang
    Charles B. Wilson
    James Fick
    Kenneth W. Culver
    John Van Gilder
    G. Evren Keles
    Alex Spence
    Mitchel Berger
    Journal of Neuro-Oncology, 2003, 65 : 269 - 278
  • [47] Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial
    Prados, MD
    McDermott, M
    Chang, SM
    Wilson, CB
    Fick, J
    Culver, KW
    Van Gilder, J
    Keles, GE
    Spence, A
    Berger, M
    JOURNAL OF NEURO-ONCOLOGY, 2003, 65 (03) : 269 - 278
  • [48] A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)
    Schwarze, Julia Katharina
    Geens, Wietse
    Tijtgat, Jens
    Awada, Gil
    Seynaeve, Laura
    Vanbinst, Anne-Marie
    Everaert, Hendrik
    Michotte, Alex
    Bruneau, Michael
    Van Riet, Ivan
    Tuyaerts, Sandra
    Duerinck, Johnny
    Neyns, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] MAGIC-G1: A PHASE 1 DOSE-ESCALATION TRIAL OF WEEKLY INTRATUMORAL ADMINISTRATION OF THE SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM)
    Desjardins, A.
    Barnes, H.
    Davies, R.
    Grant, G.
    Cavaliere, R.
    Sauvageau, E.
    Zamoryakhin, D.
    NEURO-ONCOLOGY, 2023, 25 : 117 - 117
  • [50] Results from a first-in-human phase i safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma
    Doron, Omer
    Wong, Tamika
    Ablyazova, Faina
    Singha, Souvik
    Cavallaro, Julianna
    Ben-Shalom, Netanel
    D'Amico, Randy S.
    Harshan, Manju
    Mckeown, Amy
    Zlochower, Avraham
    Langer, David J.
    Boockvar, John A.
    JOURNAL OF NEURO-ONCOLOGY, 2024, 168 (02) : 225 - 235
12345